Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2
暂无分享,去创建一个
H. Jane Dyson | Peter E. Wright | Munehito Arai | Josephine C. Ferreon | H. Dyson | P. Wright | J. Ferreon | M. Arai | Young-Ho Lee | M. Martinez-Yamout | H. Naiki | Maria A Martinez-Yamout | Chul Won Lee | Maria A. Martinez-Yamout | H. Yagi | Y. Yoshimura | 著者Josephine C. Ferreon
[1] D. Livingston,et al. Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300 , 2003, Science.
[2] A. Iserles. Numerical recipes in C—the art of scientific computing , by W. H. Press, B. P. Flannery, S. A. Teukolsky and W. T. Vetterling. Pp 735. £27·50. 1988. ISBN 0-521-35465-X (Cambridge University Press) , 1989, The Mathematical Gazette.
[3] T. Shono,et al. Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis. , 2008, Neuro-oncology.
[4] E. Appella,et al. Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress* , 2003, Journal of Biological Chemistry.
[5] E. Appella,et al. p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage , 2000, The EMBO journal.
[6] A. Fersht,et al. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 , 2007, Proceedings of the National Academy of Sciences.
[7] H. Giebler,et al. Binding of p53 to the KIX Domain of CREB Binding Protein , 1999, The Journal of Biological Chemistry.
[8] S. Berger,et al. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. , 1997, Cancer research.
[9] Kyou-Hoon Han,et al. Local Structural Elements in the Mostly Unstructured Transcriptional Activation Domain of Human p53* , 2000, The Journal of Biological Chemistry.
[10] Wei Gu,et al. Synergistic activation of transcription by CBP and p53 , 1997, Nature.
[11] R. Roeder,et al. Multivalent Binding of p53 to the STAGA Complex Mediates Coactivator Recruitment after UV Damage , 2008, Molecular and Cellular Biology.
[12] J. Cavanagh. Protein NMR Spectroscopy: Principles and Practice , 1995 .
[13] Toshiaki Hara,et al. Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. , 2006, Molecular cell.
[14] William H. Press,et al. Numerical recipes in C , 2002 .
[15] Zigang Dong,et al. Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.
[16] M. Scheffner,et al. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression , 1993, Molecular and cellular biology.
[17] Johannes Buchner,et al. The N-terminal domain of p53 is natively unfolded. , 2003, Journal of molecular biology.
[18] Wei Xu,et al. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators , 2002, Nature.
[19] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[20] L. Kay,et al. Latent and active p53 are identical in conformation , 2001, Nature Structural Biology.
[21] Zhi-Xin Wang,et al. A novel two‐site binding equation presented in terms of the total ligand concentration , 1996, FEBS letters.
[22] W. Kaelin,et al. MDM2 Suppresses p73 Function without Promoting p73 Degradation , 1999, Molecular and Cellular Biology.
[23] D. Livingston,et al. Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.
[24] M. Oren,et al. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. , 2004, Molecular cell.
[25] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[26] Jill A. Livengood,et al. p53 Transcriptional Activity Is Mediated through the SRC1-interacting Domain of CBP/p300* , 2002, The Journal of Biological Chemistry.
[27] Wei Zhang,et al. p53 Antiproliferative Function Is Enhanced by Aspartate Substitution at Threonine 18 and Serine 20 , 2002, Cancer biology & therapy.
[28] D. Herr,et al. Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression , 2006, The EMBO journal.
[29] K. Gardner,et al. Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.
[30] Yang Xu,et al. Regulation of p53 responses by post-translational modifications , 2003, Cell Death and Differentiation.
[31] Do-Hyoung Kim,et al. Structural Details on mdm2-p53 Interaction* , 2005, Journal of Biological Chemistry.
[32] R. Verdun,et al. p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. , 2003, Molecular cell.
[33] H. Dyson,et al. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. , 2004, The Biochemical journal.
[34] H. Dyson,et al. Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Hupp,et al. Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300 , 2001, EMBO reports.
[36] A. Fersht,et al. Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.
[37] Xinbin Chen,et al. Definition of the p53 Functional Domains Necessary for Inducing Apoptosis* , 2000, The Journal of Biological Chemistry.
[38] E. Appella,et al. Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.
[39] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[40] Peter E Wright,et al. Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions , 1997, Cell.
[41] R. Wadgaonkar,et al. Murine Double Minute (MDM2) Blocks p53-coactivator Interaction, a New Mechanism for Inhibition of p53-dependent Gene Expression* , 1999, The Journal of Biological Chemistry.
[42] Lee Fielding,et al. NMR methods for the determination of protein-ligand dissociation constants. , 2003, Current topics in medicinal chemistry.
[43] S. Berger,et al. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity , 1997, Oncogene.
[44] F. Kashanchi,et al. Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.
[45] D. Meek,et al. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 , 1999, The EMBO journal.
[46] K. Sakaguchi,et al. Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.
[47] H. Dyson,et al. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP. , 2000, Journal of molecular biology.
[48] C. Arrowsmith,et al. Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Livingston,et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.
[50] D. Keller,et al. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.